H19 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "H19" in Japanese language version.

refsWebsite

Global rank Japanese rank

54nih.gov

4^th place

24^th place

41doi.org

2^nd place

6^th place

5worldcat.org

5^th place

19^th place

3aacrjournals.org

8,869^th place

low place

3clinicaltrials.gov

5,225^th place

low place

2harvard.edu

18^th place

107^th place

1ensembl.org

1,626^th place

2,625^th place

1wikipedia.org

low place

1omim.org

4,380^th place

low place

1landesbioscience.com

low place

1mdanderson.org

low place

aacrjournals.org

cancerres.aacrjournals.org

clinicaltrials.gov

“Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer”. ClinicalTrials.gov. U.S. National Institutes of Health (2009年8月31日). 2010年1月14日閲覧。
“Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer With Symptomatic Ascites”. ClinicalTrials.gov. U.S. National Institutes of Health (2009年12月3日). 2010年1月14日閲覧。
“Phase 1/2a DTA-H19 in Patients With Unresentable Pancreatic Cancer”. ClinicalTrials.gov. U.S. National Institutes of Health (2009年11月9日). 2010年1月14日閲覧。

doi.org

Gabory (2009). “H19 acts as a trans regulator of the imprinted gene network controlling growth in mice”. Development 136 (20): 3413–3421. doi:10.1242/dev.036061. PMID 19762426.
“Monoallelic expression of the human H19 gene”. Nat. Genet. 1 (1): 40–44. (April 1992). doi:10.1038/ng0492-40. PMID 1363808.
“Parental imprinting of the human H19 gene”. FEBS Lett. 309 (1): 25–28. (August 1992). doi:10.1016/0014-5793(92)80731-U. PMID 1380925.
“The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15”. Biochem. Biophys. Res. Commun. 180 (3): 1241–1250. (November 1991). doi:10.1016/S0006-291X(05)81329-4. PMID 1953776.
“Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males”. Epigenetics 8 (9): 990–997. (September 2013). doi:10.4161/epi.25798. PMC 3883776. PMID 23975186.
“Establishment of functional imprinting of the H19 gene in human developing placentae”. Nat. Genet. 10 (3): 318–324. (July 1995). doi:10.1038/ng0795-318. PMID 7670470.
“The effect of retinoic acid on the activation of the human H19 promoter by a 3' downstream region”. FEBS Lett. 432 (3): 123–127. (August 1998). doi:10.1016/S0014-5793(98)00841-2. PMID 9720909.
“Loss of H19 imprinting in adult T-cell leukaemia/lymphoma”. Br. J. Haematol. 137 (4): 380–381. (May 2007). doi:10.1111/j.1365-2141.2007.06581.x. PMID 17408396.
“H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1”. J. Biol. Chem. 280 (33): 29625–29636. (August 2005). doi:10.1074/jbc.M504033200. PMID 15985428.
“Ectopic expression of the H19 gene in mice causes prenatal lethality”. Genes Dev. 5 (6): 1092–1101. (June 1991). doi:10.1101/gad.5.6.1092. PMID 2044956.
“The product of the H19 gene may function as an RNA”. Mol. Cell. Biol. 10 (1): 28–36. (January 1990). doi:10.1128/MCB.10.1.28. PMC 360709. PMID 1688465.
Juan, V.; Crain, C.; Wilson, C. (2000-03-01). “Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA”. Nucleic Acids Research 28 (5): 1221–1227. doi:10.1093/nar/28.5.1221. ISSN 1362-4962. PMC 102599. PMID 10666466.
“An enhancer deletion affects both H19 and Igf2 expression”. Genes Dev. 9 (17): 2079–2089. (September 1995). doi:10.1101/gad.9.17.2079. PMID 7544754.
“Association of IGF2 and H19 imprinting with choriocarcinoma development”. Cancer Genet. Cytogenet. 93 (1): 39–47. (January 1997). doi:10.1016/S0165-4608(96)00221-X. PMID 9062579.
“Characterization of human and mouse H19 regulatory sequences”. Mol. Biol. Rep. 27 (3): 157–165. (September 2000). doi:10.1023/A:1007139713781. PMID 11254105.
“H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium”. Int. J. Gynecol. Cancer 14 (3): 521–525. (2004). doi:10.1111/j.1048-891x.2004.014314.x. PMID 15228427.
“Steroid hormones modulate H19 gene expression in both mammary gland and uterus”. Oncogene 18 (31): 4460–4473. (August 1999). doi:10.1038/sj.onc.1202819. PMID 10442637.
“Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity”. Cancer Research 72 (24): 6403–6413. (December 2012). doi:10.1158/0008-5472.CAN-12-1155. PMID 23047867.
“Genomic imprinting in mammalian development: a parental tug-of-war”. Trends Genet. 7 (2): 45–49. (February 1991). doi:10.1016/0168-9525(91)90230-N. PMID 2035190.
“Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors”. J. Clin. Endocrinol. Metab. 87 (3): 1170–1176. (March 2002). doi:10.1210/jc.87.3.1170. PMID 11889182.
“CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain”. Cell Cycle 6 (4): 450–454. (February 2007). doi:10.4161/cc.6.4.3854. PMID 17329968.
“Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells”. Carcinogenesis 23 (11): 1885–1895. (November 2002). doi:10.1093/carcin/23.11.1885. PMID 12419837.
“The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis”. Cancer Res. 66 (10): 5330–5337. (May 2006). doi:10.1158/0008-5472.CAN-06-0037. PMID 16707459.
“The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma”. FEBS Lett. 374 (1): 57–61. (October 1995). doi:10.1016/0014-5793(95)01074-O. PMID 7589512.
Wölfl, Stefan, ed (2007). “The H19 non-coding RNA is essential for human tumor growth”. PLOS ONE 2 (9): e845. Bibcode: 2007PLoSO...2..845M. doi:10.1371/journal.pone.0000845. PMC 1959184. PMID 17786216.
“The product of the imprinted H19 gene is an oncofetal RNA”. Mol. Pathol. 50 (1): 34–44. (February 1997). doi:10.1136/mp.50.1.34. PMC 379577. PMID 9208812.
“Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer”. Eur. J. Obstet. Gynecol. Reprod. Biol. 85 (1): 7–11. (July 1999). doi:10.1016/S0301-2115(98)00275-9. PMID 10428315.
“Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma”. Oncogene 18 (50): 7063–7069. (November 1999). doi:10.1038/sj.onc.1203192. PMID 10597307.
“Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection”. Am. J. Med. Genet. 91 (1): 46–50. (March 2000). doi:10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I. PMID 10751088.
“The imprinted H19 gene as a tumor marker in bladder carcinoma”. Urology 45 (2): 335–338. (February 1995). doi:10.1016/0090-4295(95)80030-1. PMID 7855987.
“Polymorphisms in the H19 Gene and the Risk of Bladder Cancer”. Eur. Urol. 54 (5): 1118–1126. (February 2008). doi:10.1016/j.eururo.2008.01.060. PMID 18262338.
Adriaenssens, E.; Dumont, L.; Lottin, S.; Bolle, D.; Leprêtre, A.; Delobelle, A.; Bouali, F.; Dugimont, T. et al. (1998-11). “H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression”. The American Journal of Pathology 153 (5): 1597–1607. doi:10.1016/S0002-9440(10)65748-3. ISSN 0002-9440. PMC 1853398. PMID 9811352.
“Decreased sensitivity of carcinoembryonic antigen cDNA-transfected cells to adriamycin”. Int. J. Cancer 72 (2): 377–382. (July 1997). doi:10.1002/(SICI)1097-0215(19970717)72:2<377::AID-IJC29>3.0.CO;2-B. PMID 9219849.
“A prognostic multigene classifier for squamous cell carcinomas of the larynx”. Cancer Letters 307 (1): 37–46. (August 2011). doi:10.1016/j.canlet.2011.03.013. PMID 21481529.
Coorens, Tim H. H.; Treger, Taryn D.; Al-Saadi, Reem; Moore, Luiza; Tran, Maxine G. B.; Mitchell, Thomas J.; Tugnait, Suzanne; Thevanesan, Christine et al. (2019-12-06). “Embryonal precursors of Wilms tumor”. Science (New York, N.Y.) 366 (6470): 1247–1251. doi:10.1126/science.aax1323. ISSN 1095-9203. PMC 6914378. PMID 31806814.
“Possible physiological role of H19 RNA”. Mol. Carcinog. 35 (2): 63–74. (October 2002). doi:10.1002/mc.10075. PMID 12325036.
“Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA”. Oncogene 21 (10): 1625–1631. (February 2002). doi:10.1038/sj.onc.1205233. PMID 11896592.
“Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma”. Cancer Lett. 119 (2): 143–148. (November 1997). doi:10.1016/S0304-3835(97)00264-4. PMID 9570364.
“Disruption of imprinting caused by deletion of the H19 gene region in mice”. Nature 375 (6526): 34–39. (May 1995). Bibcode: 1995Natur.375...34L. doi:10.1038/375034a0. PMID 7536897.
“The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma”. Mol. Pathol. 53 (6): 320–323. (December 2000). doi:10.1136/mp.53.6.320. PMC 1186987. PMID 11193051.
“Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin”. The Journal of Urology 180 (6): 2379–2383. (December 2008). doi:10.1016/j.juro.2008.08.006. ISSN 0022-5347. PMID 18950807.